Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • PrimerBuffalo
    Junior Member
    • Mar 2017
    • 6

    #1

    Smart-seq2 sample prep questions

    Hi All,

    I have a couple questions about the Smart-seq2 method for amplifying single cells (Sandberg 2014), and I hope someone with experience in this method might have some answers:

    1) Why are dNTPs present in the catching buffer that you sort cells into? Couldn't they just be added with the RTase after the initial binding of the OligoDT to the polyA tail?

    2) What are the drawbacks of having OligoDTs or dNTPs in excess to what is written in the original protocol? I am worried about the concentrations not being enough for a highly transcriptional cell.


    Thanks in advance for the help!
  • cmbetts
    Senior Member
    • Jun 2012
    • 120

    #2
    1) If I remember right, they mention in the paper that they got a statistically significant yield increase adding dNTPs at that step. It definitely would still work, just with somewhat lower efficiency if it's added w/ RT
    2) Too much dT can generate artifacts, more dNTPs probably wouldn't have a noticeable effect. That same protocol can be used without modifying the RT conditions for bulk samples with >10ng RNA (only PCR cycles are reduced), so you don't need to worry about insufficient primer for any single cell applications. There are several orders of magnitude more primer than mRNA in the cell. You should do some preliminary characterization experiments with your cells to dial in the correct number of PCR cycles, so you might end up shaving off a cycle or two from the default if your cells are particularly active.

    Comment

    • Kaizen
      Member
      • Sep 2016
      • 13

      #3
      Do you have any experience using Smartseq2 for bulk samples? from 1000-10000 immune cells.
      I would like to know what's the maximum number of cells that you can process in a 96 well plate using bead purification without modifiying the RT-PCR and also the maximum number of cycles recommended given a certain number of cells
      Thanks
      Last edited by Kaizen; 10-18-2018, 02:58 AM.

      Comment

      • Simone78
        Senior Member
        • Oct 2010
        • 208

        #4
        Originally posted by Kaizen View Post
        Do you have any experience using Smartseq2 for bulk samples? from 1000-10000 immune cells.
        I would like to know what's the maximum number of cells that you can process in a 96 well plate using bead purification without modifiying the RT-PCR and also the maximum number of cycles recommended given a certain number of cells
        Thanks
        Hi,
        Smart-seq2 works for bulk samples, however 10K cells might be too much. Among the possible drawbacks:
        - lysis might be incomplete. To avoid this I would increase the % of Triton in the LB. You can surely increase it to 1-2% (as in the STRT-seq 2i protocol). Higher % of Triton seem also not to harm the RT enzyme but I would be cautious with that. Try to decrease the number of cells instead.
        - You might run out of some components later in the pre-ampl reaction. The most likely "candidates" are dNTPs and oligos (all). I would suggest to run a sort of titration experiment, something along the line: if you start from 1K cells do you get more cDNA after pre-ampl when using 2 uM final of TSO vs 1 uM? I know it´s just empirical but so far I didn´t come up with something better, I am afraid. If you don´t want to modify the original protocol I would try to stay in the range 100-500 cells. Maybe it works also with 1K cells, but I would at least increase the % of Triton. While the amount of RNA/cell is known for many cell types (and reported to be around 10 pg tot RNA for cell lines), I couldn´t find reliable numbers for immune cells. probably 0.1-1 pg/cell?

        With single T/B cells, ILC or monocytes I do 22-24 PCR cycles for the pre-ampl reaction. With >1 cell I would adjust the number of cycles accordingly. As a guideline: for 100 cells you might find 18-20 cycles sufficient; for 1K cells maybe 16-18, and so on. In the end you just want to have enough cDNA to be able to see it on the Agilent BA or TS. For tagmentation, both with the kit or the home-made Tn5 you would anyway use 1 ng cDNA or less. I would elute in smaller volumes after bead cleanup rather than increasing the number of pre-ampl cycles to be able to see it on the BA/TS.

        I hope this helps!
        /Simone

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
          by SEQadmin2



          CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

          Despite this, “CRISPR helped turn genome editing from a specialized technique into
          ...
          Today, 11:01 AM
        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          07-20-2026, 11:48 AM
        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, Today, 02:55 AM
        0 responses
        7 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-24-2026, 12:17 PM
        0 responses
        11 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-23-2026, 11:41 AM
        0 responses
        12 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-20-2026, 11:10 AM
        0 responses
        24 views
        0 reactions
        Last Post SEQadmin2  
        Working...